by Tina Koutouleas | May 9, 2019 | Biotech, Entrepreneurship, Life Science, Pharma
Dr. Rafel Simó Vicens has been a part of the REBBLS CORE group since August 2017. He has recently defended his Ph.D which investigated the pharmacological inhibition of KCa2 channels as a new therapeutic target for the treatment of atrial fibrillation. We asked him...
by Tina Koutouleas | Apr 15, 2019 | Biotech
How scientists are prone to pigeonholing, stunting collaboration and atomistic problem solving. A personal commentary by Tina Koutouleas What is the universe made of? How did life begin? Are we alone in the universe? What makes us human? Can computers...
by Tina Koutouleas | Mar 25, 2019 | Biotech
The CORE team at REBBLS decided that this is the year to shake things up in the Danish Life Science space by producing our very own podcast. This is a short step-by-step guide highlighting how we achieved this. At the end of the article you can find the link to listen...
by Tina Koutouleas | Feb 27, 2019 | Biotech, Entrepreneurship, Innovation, Life Science
A personal commentary by Tina Koutouleas What is Biohacking? Biohacking is anything that “hacks” i.e. improves our natural biology from microbe to human by people outside of the usual bounds of research. What comes to mind when you hear the word biohacking? If you had...
by Tina Koutouleas | Sep 3, 2018 | Biotech
Stan Cox narrates a brilliantly leery take on modern attitudes relating to sustainability, the dismal search for new markets and the relationship between the double eco – ecology and economics. The piece, published on counterpunch.org at the start of august this...
